Does the media refer more to SRTS or KRMD?

In the previous week, Sensus Healthcare had 4 more articles in the media than KORU Medical Systems. MarketBeat recorded 7 mentions for Sensus Healthcare and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.54 beat Sensus Healthcare's score of -0.32 indicating that KORU Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend SRTS or INGN?

Sensus Healthcare presently has a consensus target price of $5.83, suggesting a potential upside of 103.96%. Given Sensus Healthcare's higher probable upside, equities research analysts clearly believe Sensus Healthcare is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media refer more to SRTS or INGN?

In the previous week, Sensus Healthcare had 2 more articles in the media than Inogen. MarketBeat recorded 7 mentions for Sensus Healthcare and 5 mentions for Inogen. Inogen's average media sentiment score of 0.44 beat Sensus Healthcare's score of -0.32 indicating that Inogen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Inogen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer APYX or SRTS?

In the previous week, Apyx Medical had 13 more articles in the media than Sensus Healthcare. MarketBeat recorded 20 mentions for Apyx Medical and 7 mentions for Sensus Healthcare. Apyx Medical's average media sentiment score of -0.18 beat Sensus Healthcare's score of -0.32 indicating that Apyx Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apyx Medical 2 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Is SRTS or OWLT more profitable?

Owlet has a net margin of -8.61% compared to Sensus Healthcare's net margin of -88.45%. Owlet's return on equity of 0.00% beat Sensus Healthcare's return on equity. Company Net Margins Return on Equity Return on Assets Sensus Healthcare -88.45% -20.30% -18.05% Owlet -8.61% N/A -16.50%

Does the media favor SRTS or OWLT?

In the previous week, Owlet had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 8 mentions for Owlet and 7 mentions for Sensus Healthcare. Owlet's average media sentiment score of 0.55 beat Sensus Healthcare's score of -0.32 indicating that Owlet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Owlet 0 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SRTS or STIM?

In the previous week, Neuronetics had 8 more articles in the media than Sensus Healthcare. MarketBeat recorded 15 mentions for Neuronetics and 7 mentions for Sensus Healthcare. Neuronetics' average media sentiment score of 0.61 beat Sensus Healthcare's score of -0.32 indicating that Neuronetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Neuronetics 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Sensus Healthcare (SRTS) Competitors

$2.86 -0.30 (-9.49%)

Closing price 04:00 PM Eastern

Extended Trading

$2.86 +0.01 (+0.17%)

As of 07:34 PM Eastern

Compare

SRTS vs. KRMD, INGN, APYX, OWLT, and STIM

Should you buy Sensus Healthcare stock or one of its competitors? Sensus Healthcare's main competitors and comparable companies include KORU Medical Systems (KRMD), Inogen (INGN), Apyx Medical (APYX), Owlet (OWLT), and Neuronetics (STIM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sensus Healthcare compare to KORU Medical Systems?

Sensus Healthcare (NASDAQ:SRTS) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Sensus Healthcare currently has a consensus target price of $5.83, indicating a potential upside of 103.96%. KORU Medical Systems has a consensus target price of $7.00, indicating a potential upside of 105.88%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Sensus Healthcare has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

KORU Medical Systems has a net margin of -4.03% compared to Sensus Healthcare's net margin of -88.45%. KORU Medical Systems' return on equity of -10.63% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-20.30%	-18.05%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

In the previous week, Sensus Healthcare had 4 more articles in the media than KORU Medical Systems. MarketBeat recorded 7 mentions for Sensus Healthcare and 3 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.54 beat Sensus Healthcare's score of -0.32 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensus Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

KORU Medical Systems has higher revenue and earnings than Sensus Healthcare. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.71	-$7.72M	-$0.47	N/A
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A

Summary

KORU Medical Systems beats Sensus Healthcare on 12 of the 15 factors compared between the two stocks.

How does Sensus Healthcare compare to Inogen?

Sensus Healthcare (NASDAQ:SRTS) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

In the previous week, Sensus Healthcare had 2 more articles in the media than Inogen. MarketBeat recorded 7 mentions for Sensus Healthcare and 5 mentions for Inogen. Inogen's average media sentiment score of 0.44 beat Sensus Healthcare's score of -0.32 indicating that Inogen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensus Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Inogen	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sensus Healthcare has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Inogen has a beta of 1.55, meaning that its stock price is 55% more volatile than the broader market.

Inogen has a net margin of -6.94% compared to Sensus Healthcare's net margin of -88.45%. Inogen's return on equity of -13.17% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-20.30%	-18.05%
Inogen	-6.94%	-13.17%	-8.36%

Sensus Healthcare has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.71	-$7.72M	-$0.47	N/A
Inogen	$348.67M	0.44	-$22.75M	-$0.90	N/A

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sensus Healthcare presently has a consensus target price of $5.83, suggesting a potential upside of 103.96%. Given Sensus Healthcare's higher probable upside, equities research analysts clearly believe Sensus Healthcare is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Sensus Healthcare and Inogen tied by winning 8 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Sensus Healthcare has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.42	-$11.21M	-$0.20	N/A
Sensus Healthcare	$27.48M	1.71	-$7.72M	-$0.47	N/A

Apyx Medical has a net margin of -14.78% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -20.30% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Sensus Healthcare	-88.45%	-20.30%	-18.05%

Apyx Medical presently has a consensus price target of $6.60, suggesting a potential upside of 117.82%. Sensus Healthcare has a consensus price target of $5.83, suggesting a potential upside of 103.96%. Given Apyx Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Apyx Medical is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Apyx Medical has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market.

In the previous week, Apyx Medical had 13 more articles in the media than Sensus Healthcare. MarketBeat recorded 20 mentions for Apyx Medical and 7 mentions for Sensus Healthcare. Apyx Medical's average media sentiment score of -0.18 beat Sensus Healthcare's score of -0.32 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	2 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Sensus Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Apyx Medical beats Sensus Healthcare on 13 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to Owlet?

Sensus Healthcare (NASDAQ:SRTS) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Owlet has a net margin of -8.61% compared to Sensus Healthcare's net margin of -88.45%. Owlet's return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-20.30%	-18.05%
Owlet	-8.61%	N/A	-16.50%

Sensus Healthcare currently has a consensus price target of $5.83, suggesting a potential upside of 103.96%. Owlet has a consensus price target of $15.00, suggesting a potential upside of 122.82%. Given Owlet's higher probable upside, analysts plainly believe Owlet is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Sensus Healthcare has higher earnings, but lower revenue than Owlet. Sensus Healthcare is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.71	-$7.72M	-$0.47	N/A
Owlet	$105.70M	1.85	-$39.68M	-$3.07	N/A

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 36.2% of Owlet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Sensus Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, Owlet has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market.

In the previous week, Owlet had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 8 mentions for Owlet and 7 mentions for Sensus Healthcare. Owlet's average media sentiment score of 0.55 beat Sensus Healthcare's score of -0.32 indicating that Owlet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensus Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Owlet	0 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Owlet beats Sensus Healthcare on 11 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to Neuronetics?

Sensus Healthcare (NASDAQ:SRTS) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Neuronetics had 8 more articles in the media than Sensus Healthcare. MarketBeat recorded 15 mentions for Neuronetics and 7 mentions for Sensus Healthcare. Neuronetics' average media sentiment score of 0.61 beat Sensus Healthcare's score of -0.32 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sensus Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Neuronetics	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Sensus Healthcare has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by insiders. Comparatively, 8.4% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sensus Healthcare currently has a consensus price target of $5.83, indicating a potential upside of 103.96%. Neuronetics has a consensus price target of $4.50, indicating a potential upside of 36.36%. Given Sensus Healthcare's higher possible upside, equities research analysts clearly believe Sensus Healthcare is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Neuronetics has a net margin of -19.62% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -20.30% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-20.30%	-18.05%
Neuronetics	-19.62%	-125.11%	-22.15%

Sensus Healthcare has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.71	-$7.72M	-$0.47	N/A
Neuronetics	$149.16M	1.69	-$39M	-$0.54	N/A

Summary

Sensus Healthcare beats Neuronetics on 10 of the 15 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTS vs. The Competition

Export

Metric	Sensus Healthcare	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$52.02M	$5.95B	$7.06B	$13.10B
Dividend Yield	N/A	1.76%	2.57%	10.45%
P/E Ratio	-3.04	21.85	211.09	21.74
Price / Sales	1.71	63.14	602.98	92.99
Price / Cash	N/A	33.92	70.48	50.90
Price / Book	0.98	6.10	12.91	6.24
Net Income	-$7.72M	$148.67M	$3.45B	$347.60M
7 Day Performance	-6.84%	1.84%	1.12%	1.07%
1 Month Performance	-7.14%	4.56%	1.79%	1.03%
1 Year Performance	-16.86%	8.67%	67.69%	20.77%

Sensus Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTS Sensus Healthcare	1.8605 of 5 stars	$2.86 -9.5%	$5.83 +104.0%	-7.6%	$52.02M	$27.48M	N/A	40	News Coverage Earnings Report Analyst Forecast Gap Down High Trading Volume
KRMD KORU Medical Systems	3.8941 of 5 stars	$4.24 +0.2%	$7.25 +71.0%	-22.6%	$194.97M	$41.13M	N/A	80
INGN Inogen	1.2646 of 5 stars	$6.80 +1.4%	N/A	-24.5%	$183.87M	$351.50M	N/A	1,030
APYX Apyx Medical	2.0544 of 5 stars	$4.31 +3.1%	$6.60 +53.1%	+29.4%	$182.98M	$52.84M	N/A	270	News Coverage Analyst Revision
OWLT Owlet	2.9825 of 5 stars	$5.53 +1.8%	$15.00 +171.2%	-18.4%	$160.67M	$105.70M	N/A	106	News Coverage Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTS) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sensus Healthcare (SRTS) Competitors

SRTS vs. KRMD, INGN, APYX, OWLT, and STIM

How does Sensus Healthcare compare to KORU Medical Systems?

Summary

How does Sensus Healthcare compare to Inogen?

Summary

How does Sensus Healthcare compare to Apyx Medical?

Summary

How does Sensus Healthcare compare to Owlet?

Summary

How does Sensus Healthcare compare to Neuronetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sensus Healthcare (SRTS) Competitors

SRTS vs. KRMD, INGN, APYX, OWLT, and STIM

How does Sensus Healthcare compare to KORU Medical Systems?

Do analysts rate SRTS or KRMD?

Which has more risk and volatility, SRTS or KRMD?

Do institutionals & insiders have more ownership in SRTS or KRMD?

Is SRTS or KRMD more profitable?

Does the media refer more to SRTS or KRMD?

Which has higher earnings and valuation, SRTS or KRMD?

Summary

How does Sensus Healthcare compare to Inogen?

Does the media refer more to SRTS or INGN?

Which has more volatility & risk, SRTS or INGN?

Is SRTS or INGN more profitable?

Which has preferable earnings and valuation, SRTS or INGN?

Do insiders & institutionals hold more shares of SRTS or INGN?

Do analysts recommend SRTS or INGN?

Summary

How does Sensus Healthcare compare to Apyx Medical?

Which has higher valuation and earnings, APYX or SRTS?

Is APYX or SRTS more profitable?

Do analysts rate APYX or SRTS?

Which has more risk and volatility, APYX or SRTS?

Does the media prefer APYX or SRTS?

Do institutionals & insiders have more ownership in APYX or SRTS?

Summary

How does Sensus Healthcare compare to Owlet?

Is SRTS or OWLT more profitable?

Do analysts rate SRTS or OWLT?

Which has better valuation & earnings, SRTS or OWLT?

Do insiders and institutionals have more ownership in SRTS or OWLT?

Which has more risk and volatility, SRTS or OWLT?

Does the media favor SRTS or OWLT?

Summary

How does Sensus Healthcare compare to Neuronetics?

Does the media favor SRTS or STIM?

Which has more volatility and risk, SRTS or STIM?

Do institutionals and insiders have more ownership in SRTS or STIM?

Do analysts prefer SRTS or STIM?

Is SRTS or STIM more profitable?

Which has preferable earnings & valuation, SRTS or STIM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools